Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1376387 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
Abstract
4-(1,3-Thiazol-2-yl)morpholine derivatives have been identified as potent and selective inhibitors of phosphoinositide 3-kinase. The SAR data of selected examples are presented and the in vivo profiling of compound 18 is shown to demonstrate the utility of this class of compounds in xenograft models of tumor growth.
Graphical abstract4-(1,3-Thiazol-2-yl)morpholine derivatives have been identified as potent and selective inhibitors of phosphoinositide 3-kinase, compound 18 is shown to demonstrate the utility of this class of compounds in xenograft models of tumor growth.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Rikki Alexander, Ahrani Balasundaram, Mark Batchelor, Daniel Brookings, Karen Crépy, Tom Crabbe, Marie-France Deltent, Frank Driessens, Andrew Gill, Sue Harris, Gillian Hutchinson, Claire Kulisa, Mark Merriman, Prakash Mistry, Ted Parton, James Turner,